Fergal Fleming

Fergal Fleming, MB BCh BAO, MD, FRCS is an Associate Professor of Surgery and Oncology at the University of Rochester Medical Center. As a Fellow in the URMC Division of Colorectal Surgery since 2009, he specializes in colorectal cancer surgery, minimally invasive techniques, and quality improvement in surgical care. He is affiliated with the Wilmot Cancer Institute and the PelvEx Collaborative, which focuses on pelvic exenteration outcomes and guidelines.

• Current Appointments: Department of Surgery, Colorectal Surgery
• Professional Memberships: American Society of Colon and Rectal Surgeons, Society of Surgical Oncology, Royal Academy of Medicine in Ireland
• Education: MBBCH from University College Dublin (1998)
• Licensure: State of New York and Irish Medical Council Specialist Register

Dr. Fleming's research spans rectal cancer management, nonoperative strategies, and healthcare disparities. His recent work explores the watch-and-wait approach, impact of surgeon volume on outcomes, and metabolic syndrome in surgical complications. He has published extensively in journals like Annals of Surgical Oncology and Diseases of the Colon and Rectum.

His scientific contributions include 15+ recent articles on topics such as ileostomy reversal outcomes, acute kidney injury in colorectal patients, and geriatric syndromes affecting postoperative recovery. He collaborates with multidisciplinary teams across institutions like the Wilmot Cancer Center and the PelvEx Collaborative.

• 2024: Victor W. Fazio Award for Editorial Excellence
• 2015-2018: James P Wilmot Cancer Research Fellowship
• 2007: National Cancer Institute Diploma in Cancer Chemoprevention
• 2004: JMS Doctor Award (Surgical Section)
• 2002: RCSI/SARS Surgical Research Fellowship

Dr. Fleming's clinical trials, including the COSMID Study, compare surgical and medical interventions for diverticulitis. His work emphasizes patient-centered outcomes, cost-effectiveness, and implementation of best practices in colorectal care.